Scientific Conferences
2010 & 2011
11th International Alzheimer’s Disease Drug Discovery Conference
September 27-28, 2010, Jersey City, New Jersey
A two-day global conference for research scientists to engage in discussion and cross fertilization of ideas focusing on Alzheimer’s drug discovery research. The conference objectives are to: (1) discuss scientific progress on drug discovery programs aimed at treating Alzheimer’s disease and related dementias; (2) increase networking opportunities for scientists to share information and resources; and (3) publish a post-meeting report in a scientific journal. The meeting attracts about 150 participants from around the world.
Conference Website
Feeding the Pipeline: Novel Targets for Alzheimer’s Drug Discovery
November 3, 2010, Toulouse, France
A one-day meeting focusing on European biotechnology companies conducting early-stage high risk research for Alzheimer’s disease that complement approaches in advanced clinical trials. This is a satellite meeting to be held in conjunction with the 3rd Clinical Trials on Alzheimer’s Disease conference.
Conference Website
ADDF to Exhibit at the Society for Neuroscience Conference
November 13-17, 2010, San Diego, California
The Alzheimer’s Drug Discovery Foundation is pleased to be exhibiting at the annual Society for Neuroscience (SfN) conference. This annual meeting attracts over 30,000 participants. You can find the ADDF at Booth#: 3806.
6th International Pharmacoeconomic Conference on Alzheimer’s Disease
February 3-4, 2011, London, England
IPECAD is the only conference that exclusively addresses issues related to the economic evaluation of drug treatments for Alzheimer’s disease, bringing together leading experts and opinion leaders from the academia, regulatory bodies and the pharmaceutical industry. ADDF co-hosts the meeting with the Karolinska Institutet, Stockholm.
Conference Website Coming Soon
5th Drug Discovery for Neurodegeneration:
An intensive course on translating research into drugs
February 6-8, 2011, San Diego, California
Designed as a comprehensive course, this two-day conference provides participants with the fundamental knowledge and resources on creating new drugs to treat and prevent neurodegenerative disease. Case studies on Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, Amyotrophic Lateral Sclerosis and Multiple Sclerosis will be included in the discussions. The meeting attracts about 140 participants from around the world.
Conference Website
For more information about an upcoming conference, please contact Filomena Machleder at 212-901-8004 or fmachleder@alzdiscovery.org.